Therapeutic strategies for spinal muscular atrophy: the history and future perspective
The history of SMA research and therapy development is traced, the three approved treatments are critically compared, and key unresolved challenges including treatment-switching criteria, management of late-diagnosed patients, and the emerging role of biomarkers such as neurofilament light chain and compound muscle act...